Artificial Intelligence in Drug Repurposing
Researchers at Harvard Medical School have developed an AI tool named TxGNN, designed to identify new therapeutic uses for existing drugs, particularly targeting rare diseases lacking FDA-approved treatments. TxGNN has evaluated drug candidates for over 17,000 conditions, offering a comprehensive approach to drug repurposing. Similarly, the Advanced Research Projects Agency for Health (ARPA-H) has launched […]
Continue Reading
